Search Results 1791-1800 of 18755 for Activation

  1. Publications - Gary L. Keeney, M.D. - Mayo Clinic

    Dashti NK, Swanson AA, Keeney GL, Edgar MA, Gupta S, Schoolmeester JK. Alterations of G-protein Activating Subunit Genes in Ovarian Hemangiomas: A Molecular ...

  2. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

    Activated partial thromboplastin time (aPTT) ≤ 1.5 x ULN unless patient is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range ...

  3. A Study of Catequentinib, Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma - Mayo Clinic

    International normalize ratio (INR) and the activated partial thromboplastin time (aPTT/PTT) ≤ 1.5 x ULN. (Subjects who are therapeutically treated with an ...

  4. Publications - Thomas M. Habermann, M.D. - Mayo Clinic

    ... activated B-cell-like subpopulation with targetable MYC dysregulation. Nat Commun. 2024 Aug 8; 15 (1):6790 Epub 2024 Aug 08. View PubMed; Laoruangroj C ...

  5. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

    Screening values of coagulation parameters including platelet count, international normalized ratio (INR), prothrombin time (PT), and activated partial ...

  6. Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration - Mayo Clinic Research

    Transcriptional activation of key genes and pathways are being interrogated for potential insights into susceptibility to multikinase inhibitors and ...

  7. Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) - Mayo Clinic

    - Platelets < 100x10^9 /L. - International normalized ratio (INR) > 1.5x ULN or activated partial thromboplastin time (aPTT) > 1.5x ULN (unless due to known ...

  8. Ablation Therapy Clinical Trials - Mayo Clinic Research

    The goal of the study is to identify immune responses (immune cell activation and suppression) following local ablation of liver tumors. A Study to Evaluate ...

  9. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

    ... activation and propagation. When these viruses were injected into B16.OVA melanoma tumors in animals concomitantly receiving programmed cell-death protein 1 ...

  10. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome - Mayo Clinic

    - Presence of a non-ITD FLT3 activating mutation and positive MRD (≥ 0.05%) at end of Induction 1 regardless of presence of favorable genetic markers ...